Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Flow Cytometry01:23

Flow Cytometry

16.5K
The development of flow cytometry techniques began in 1934 with initial attempts by Andrew Moldavan, a bacteriologist who counted the cells in a flowing capillary system. Moldavan pumped cells through a capillary tube focused under a microscope for visualization. The invention of photometry allowed the measurement of differentially-stained cells, and Louis Kamentsky developed the first multiparameter flow cytometer in 1965 to identify and count the cancer cells in cervical tissue specimens.
In...
16.5K
Antibiotic Selection00:57

Antibiotic Selection

60.3K
Overview
60.3K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.6K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.6K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

655
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
655
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

1.6K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Idler Compounds: A Simple Protocol for Openly Sharing Fridge Contents for Cross-Screening.

Journal of medicinal chemistry·2026
Same author

Nitric oxide induces the distinct invisibility phenotype of Mycobacterium tuberculosis.

Communications biology·2024
Same author

Navigating fluoroquinolone resistance in Gram-negative bacteria: a comprehensive evaluation.

JAC-antimicrobial resistance·2024
Same author

EfpA is required for regrowth of <i>Mycobacterium tuberculosis</i> following isoniazid exposure.

Antimicrobial agents and chemotherapy·2024
Same author

A Microtiter Plate Assay at Acidic pH to Identify Potentiators that Enhance Pyrazinamide Activity Against Mycobacterium tuberculosis.

Methods in molecular biology (Clifton, N.J.)·2024
Same author

A combination of nirmatrelvir and ombitasvir boosts inhibition of SARS-CoV-2 replication.

Antiviral research·2024

Related Experiment Video

Updated: Feb 15, 2026

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence
09:11

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence

Published on: January 27, 2023

2.8K

A Flow Cytometry Method for Assessing M. tuberculosis Responses to Antibiotics.

Charlotte L Hendon-Dunn1, Stephen R Thomas1, Stephen C Taylor1

  • 1Research, National Infectious Service, Public Health England, Salisbury, UK.

Methods in Molecular Biology (Clifton, N.J.)
|January 12, 2018
PubMed
Summary
This summary is machine-generated.

This study introduces a rapid fluorescence method to quickly assess Mycobacterium tuberculosis antibiotic susceptibility. The new technique offers faster results and captures more comprehensive data on bacterial viability compared to traditional culture methods.

Keywords:
Antibiotic susceptibilityCalcein violet-AMFlow cytometryMycobacterium tuberculosisSYTOX-green

More Related Videos

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection
10:43

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection

Published on: September 18, 2020

32.7K
The Use of Flow Cytometry to Assess the State of Chromatin in T Cells
11:01

The Use of Flow Cytometry to Assess the State of Chromatin in T Cells

Published on: December 17, 2015

17.4K

Related Experiment Videos

Last Updated: Feb 15, 2026

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence
09:11

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence

Published on: January 27, 2023

2.8K
Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection
10:43

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection

Published on: September 18, 2020

32.7K
The Use of Flow Cytometry to Assess the State of Chromatin in T Cells
11:01

The Use of Flow Cytometry to Assess the State of Chromatin in T Cells

Published on: December 17, 2015

17.4K

Area of Science:

  • Microbiology
  • Molecular Biology
  • Drug Discovery

Background:

  • Traditional drug susceptibility testing for Mycobacterium tuberculosis is time-consuming, often requiring weeks for results.
  • Existing methods may not accurately assess the viability of all bacteria, particularly those not immediately culturable.
  • There is a need for rapid and comprehensive methods to determine tuberculosis drug susceptibility.

Purpose of the Study:

  • To develop and validate a rapid fluorescence-based method for assessing Mycobacterium tuberculosis antibiotic susceptibility.
  • To provide a faster alternative to traditional culture-based drug susceptibility testing.
  • To gain insights into the concentration- and time-dependent activity of antibiotics against M. tuberculosis.

Main Methods:

  • Utilized fluorescent viability markers Calcein violet-AM (for live cells) and SYTOX-green (for dead cells).
  • Applied the method to Mycobacterium tuberculosis post-antibiotic exposure.
  • Measured fluorescence to determine cell viability and assess drug susceptibility.

Main Results:

  • The fluorescence detection method provides a rapid readout of drug susceptibility.
  • The technique captures susceptibility information from the entire bacterial population, including non-culturable cells.
  • The method offers insights into antibiotic concentration and time-dependent activity.

Conclusions:

  • This rapid fluorescence method offers a significant improvement over traditional drug susceptibility testing for M. tuberculosis.
  • The technique provides faster and more comprehensive data on antibiotic efficacy.
  • This approach has the potential to accelerate tuberculosis treatment decisions and drug development.